Johnson & Johnson (JNJ) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar CompetitionMarketBeat • 09/14/26
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your PortfolioZacks Investment Research • 09/14/26
Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancerPRNewsWire • 09/14/26
The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind24/7 Wall Street • 09/12/26
These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them24/7 Wall Street • 09/11/26
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact LensesBusiness Wire • 09/10/26
Johnson & Johnson (JNJ) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center StageMarketBeat • 09/09/26
Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026PRNewsWire • 09/08/26
JEPI Is an Income Machine—But These 3 Dividend Stocks Don't Cap Your Upside24/7 Wall Street • 09/08/26
Which Defensive Stock Has Dominated in 2026: Coca-Cola, Johnson & Johnson, or Procter & Gamble?24/7 Wall Street • 09/07/26
J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?Zacks Investment Research • 09/02/26
Johnson & Johnson Replaced $913 Million In Lost Sales With $2.4 Billion In New Ones - But Kept Less Than HalfSeeking Alpha • 09/02/26